13 September 2011

Top VCs, Pharma Execs and TTOs meeting at the TTS Europe in Paris

With less than one week to go to the Tech Transfer Summit Europe in Paris, the leading stakeholders are converting the TTS Europe into the key high-level, interactive biotech business meeting for early-stage biotech and industry licensing from universities and start-ups.

Meet, & join roundtable discussions with Europe's Top VCs, Pharma Licensing Executives, and Tech Transfer Officers.

Yes, the TTS Europe has Partnering, but more importantly, 2 full days of interactive discussion, debate & deal-making

Why are the coming? None of the TTS Initiative Summits are large. There are no exhibitions. No company presentations in empty rooms. And no one brings their marketing staff.

But the TTS Europe is unique. It is pure, interactive roundtable discussion with many of Europe's most important Venture Capital Investors.

It is direct access and discussions over 2 days with many senior Pharma Licensing & Business Development Executives.

Networking and deal-making at its best.

See the website for full details, but know that the following VCs, Pharma, and University and Institute Tech Transfer Offices are all confimed:

Edmond de Rothschild Investment Partners
Apposite Capital
Crédit Agricole Private Equity
Heartstream Group
Index Ventures
KLS Partners
Merieux Developpment
BioAssetInvestETH Zurich
MRC Technology
Inserm Transfert
INRIA
Universidad de Valparaiso
Institut Pasteur
Fundacio Parc Tauli
Trinity College Dublin
Erasmus Medical Centre
Aviesan Alliance
GSK
Pfizer
Sanofi
Genzyme
Boehringer Ingelheim
Merck Sharp & Dohme
Pfizer Animal Health
Debiopharm
L’Oréal

And many more. See you there